课题基金 / 基金详情

Innate and adaptive immune responses to Leishmania

Innate and adaptive immune responses to Leishmania
对利什曼原虫的先天和适应性免疫反应
批准号:
6777245
负责人:
DAVID M MOSSER
金额:
$33.41万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-01 至 2005-04-30

项目摘要

项目成果

DAVID M MOSSER的其他基金

相似基金

相关文献

中文摘要
翻译
这一建议的中心假设是利什曼原虫。能够操纵宿主的先天免疫反应和获得性免疫反应,使之成为自己的优势。该提案的第一个目标是关注利什曼原虫操纵先天免疫反应的能力,第二个目标是关注寄生虫操纵适应性免疫反应的能力。这项提议是建立在实验室中两个独立的、令人惊讶的观察结果之上的。该提案的第一个目的是建立在观察到巨噬细胞和DC感染利什曼原虫前鞭毛体未能诱导细胞因子产生或APC成熟的基础上。因此,我们假设利什曼原虫不能参与宿主的先天免疫反应。我们将在目标1中提出的主要问题是,未能激活先天免疫是否是一个关键问题 成分对寄生虫的致病力。为了提出这个问题,我们开发了转基因利什曼原虫,它确实能与巨噬细胞和DC上的Toll样受体(TLRs)结合。我们计划研究这些生物的生物学,并确定它们是否以不同的方式呈现给T细胞,它们是否会引起与野生型生物不同的损伤,以及它们是否会在质量和数量上引发不同的适应性免疫反应。第二个目的是基于观察到缺乏重链免疫球蛋白的小鼠(JH小鼠)对主要乳杆菌感染具有抵抗力,尽管它们是BALB/c易感背景。向这些小鼠体内注入免疫血清实际上会增加病变进展和寄生虫复制。 我们计划确定免疫球蛋白是如何对感染了细胞内寄生虫的宿主有害的。我们假设免疫球蛋白导致APC产生IL-10,我们将确定APC衍生的IL-10对该生物体的适应性免疫反应的影响程度。我们将确定免疫球蛋白免疫复合体的存在会改变适应性免疫反应的哪些方面。这些研究不仅直接与利什曼原虫的免疫有关,还可能提供关于细胞内病原体的免疫共振以及APC在调节适应性免疫反应中的作用的基本信息。
英文摘要
The central hypothesis of this proposal is that Leishmania spp. are able to manipulate both the innate and the adaptive immune responses of the host to their advantage. The first aim of the proposal focuses on the ability of Leishmania to manipulate the innate immune response, and the second aim focuses on the ability of the parasite to manipulate the adaptive immune response. The proposal is built on two separate and surprising observations that were made in the lab. The first aim of the proposal is built on the observation that infection of macrophages and DC with Leishmania promastigotes fails to induce cytokine production or APC maturation. Thus we hypothesized that Leishmania fail to engage the innate immune responses of the host. The main question we will ask in Aim 1 is whether this failure to activate innate immunity is a critical component to parasite virulence. To ask this question, we have developed transgenic Leishmania that do engage Toll-Like Receptors (TLRs) on macrophages and DC. We plan to study the biology of these organisms and determine whether they are presented to T cells differently, whether they cause lesions that are different from wild-type organisms, and whether they induce qualitatively and quantitatively different adaptive immune responses. The second aim is based on the observation that mice lacking the heavy chain of IgG (JH mice) are resistant to L. major infection, despite being on the susceptible BALB/c background. The infusion of immune serum into these mice actually increases lesion progression and parasite replication. We plan to determine how IgG can work to the detriment of the host infected with an intracellular parasite. We hypothesize that IgG leads to IL-10 production by APCs, and we will determine the extent to which APCderived IL-10 influences adaptive immune responses to this organism. We will determine which aspects of the adaptive immune response are altered by the presence of IgG immune complexes. These studies not only pertain directly to Leishmania immunity, but they may also provide basic general information about theimmune resonse to intracellular pathogens, and about the role of APCs in modulating adaptive immune responses.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
A role for IgG immune complexes during infection with the intracellular pathogen Leishmania.
IgG免疫复合物在感染Leishmania的感染过程中的作用。
DOI: 10.1084/jem.20041470
发表时间: 2005-03-07
期刊: JOURNAL OF EXPERIMENTAL MEDICINE
影响因子: 15.3
作者: [Miles, SA, Conrad, SM, Aves, RG, Jeronimo, SMB, Mosser, DM]
通讯作者: Mosser, DM
Treating collagen-induced arthritis (CIA) with immunoregulatory nanoparticles
  • 批准号:
    9047174
  • 项目类别:
  • 资助金额:
    $17.95万
  • 财政年份:
    2016
  • 负责人:
    DAVID M MOSSER
  • 依托单位:
Treating collagen-induced arthritis (CIA) with immunoregulatory nanoparticles
  • 批准号:
    9378465
  • 项目类别:
  • 资助金额:
    $4.55万
  • 财政年份:
    2016
  • 负责人:
    DAVID M MOSSER
  • 依托单位:
Regulatory macrophages and the host inflammatory response
  • 批准号:
    8642658
  • 项目类别:
  • 资助金额:
    $28.88万
  • 财政年份:
    2013
  • 负责人:
    DAVID M MOSSER
  • 依托单位:
Regulatory macrophages and the host inflammatory response
  • 批准号:
    9021661
  • 项目类别:
  • 资助金额:
    $28.88万
  • 财政年份:
    2013
  • 负责人:
    DAVID M MOSSER
  • 依托单位:
海外基金